These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
498 related items for PubMed ID: 17533587
1. The effect of stem cell mobilisation with granulocyte colony-stimulating factor on the morphology of the haematopoietic organs in mice. Barcew K, Paczkowska E, Dabkowska E, Baskiewicz-Masiuk M, Marchlewicz M, Domański L, Sagan L, Wiszniewska B, Machaliński B. Folia Morphol (Warsz); 2007 Feb; 66(1):1-9. PubMed ID: 17533587 [Abstract] [Full Text] [Related]
4. Repeated hematopoietic stem and progenitor cell mobilization without depletion of the bone marrow stem and progenitor cell pool in mice after repeated administration of recombinant murine G-CSF. de Kruijf EJ, van Pel M, Hagoort H, Kruysdijk D, Molineux G, Willemze R, Fibbe WE. Hum Immunol; 2007 May; 68(5):368-74. PubMed ID: 17462504 [Abstract] [Full Text] [Related]
9. G-CSF during large field radiotherapy reduces bone marrow recovery capacity. Pape H, Orth K, Heese A, Heyll A, Kobbe G, Schmitt G, Niederbichler AD, Peiper M, Schwarz A, Boelke E. Eur J Med Res; 2006 Aug 30; 11(8):322-8. PubMed ID: 17052967 [Abstract] [Full Text] [Related]
10. G-CSF-primed hematopoietic stem cells or G-CSF per se accelerate recovery and improve survival after liver injury, predominantly by promoting endogenous repair programs. Yannaki E, Athanasiou E, Xagorari A, Constantinou V, Batsis I, Kaloyannidis P, Proya E, Anagnostopoulos A, Fassas A. Exp Hematol; 2005 Jan 30; 33(1):108-19. PubMed ID: 15661404 [Abstract] [Full Text] [Related]
11. Effects of short-term administration of G-CSF (filgrastim) on bone marrow progenitor cells: analysis of serial marrow samples from normal donors. Martínez C, Urbano-Ispizua A, Rozman M, Rovira M, Marín P, Montfort N, Carreras E, Montserrat E. Bone Marrow Transplant; 1999 Jan 30; 23(1):15-9. PubMed ID: 10037045 [Abstract] [Full Text] [Related]
15. Differential effects of granulocyte colony-stimulating factor on marrow- and blood-derived hematopoietic and immune cell populations in healthy human donors. Shier LR, Schultz KR, Imren S, Regan J, Issekutz A, Sadek I, Gilman A, Luo Z, Panzarella T, Eaves CJ, Couban S. Biol Blood Marrow Transplant; 2004 Sep 30; 10(9):624-34. PubMed ID: 15319774 [Abstract] [Full Text] [Related]
16. In vivo activity of the cleaved form of soluble urokinase receptor: a new hematopoietic stem/progenitor cell mobilizer. Selleri C, Montuori N, Ricci P, Visconte V, Baiano A, Carriero MV, Rotoli B, Rossi G, Ragno P. Cancer Res; 2006 Nov 15; 66(22):10885-90. PubMed ID: 17108125 [Abstract] [Full Text] [Related]
20. Feasibility and safety of G-CSF administration to induce bone marrow-derived cells mobilization in patients with end stage liver disease. Gaia S, Smedile A, Omedè P, Olivero A, Sanavio F, Balzola F, Ottobrelli A, Abate ML, Marzano A, Rizzetto M, Tarella C. J Hepatol; 2006 Jul 15; 45(1):13-9. PubMed ID: 16635534 [Abstract] [Full Text] [Related] Page: [Next] [New Search]